News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current QGEN market cap is 9.37B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 499.63M | 499.49M | 485.4M | 494.86M | 475.89M |
| Operating Income | 30.78M | 106.44M | 96.71M | 105.43M | 35.05M |
| Net Income | 82.39M | 241.29M | 85.04M | 80.79M | 77.82M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.5B | 1.53B | 1.87B | 2.25B | 2.14B |
| Operating Income | 275.14M | -47.45M | 383.92M | 635.68M | 533.32M |
| Net Income | 104.89M | -69.77M | 73.64M | 537.05M | 575.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.52B | 6.35B | 6.28B | 6.35B | 5.91B |
| Total Liabilities | 3.19B | 2.96B | 2.72B | 2.72B | 2.21B |
| Total Equity | 3.33B | 3.39B | 3.56B | 3.62B | 3.69B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.8B | 5.26B | 5.93B | 6.21B | 6.35B |
| Total Liabilities | 3.42B | 2.94B | 3.45B | 3.35B | 2.96B |
| Total Equity | 2.38B | 2.32B | 2.48B | 2.86B | 3.39B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 590.95M | 751.12M | 71.93M | 183.4M | 308.09M |
| Investing | -602.24M | -735.58M | -433.85M | -277.57M | -29.2M |
| Financing | 420.57M | -152.65M | -9.83M | -25.3M | -426.39M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 363.47M | 367.03M | 492.27M | 675.99M | 751.12M |
| Investing | -215.33M | -236.96M | -503.06M | -211.7M | -735.58M |
| Financing | 360.41M | -661.75M | -74.32M | -177.8M | -152.65M |
| Market Cap | 9.37B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 227.72M |
| Average Volume (1 week) | 1.12M |
| Average Volume (1 Month) | 1.12M |
| 52 Week Change | -15.59% |
| 52 Week High | 51.18 |
| 52 Week Low | 34.74 |
| Spread (Intraday) | 26.63 (61.5%) |
| Company Name | Qiagen NV |
| Address |
hulsterweg 82 venlo, limburg 5912-PL |
| Website | https://www.qiagen.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
